- Home
- APGE vs ALVO Comparison
APGE vs ALVO Comparison
Compare APGE & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- ALVO
- Stock Information
- Founded
- APGE 2022
- ALVO 2013
- Country
- APGE United States
- ALVO Luxembourg
- Employees
- APGE N/A
- ALVO N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- APGE Health Care
- ALVO Health Care
- Exchange
- APGE Nasdaq
- ALVO Nasdaq
- Market Cap
- APGE 2.4B
- ALVO 2.5B
- IPO Year
- APGE 2023
- ALVO N/A
- Fundamental
- Price
- APGE $55.35
- ALVO $7.90
- Analyst Decision
- APGE Strong Buy
- ALVO Strong Buy
- Analyst Count
- APGE 8
- ALVO 2
- Target Price
- APGE $94.63
- ALVO $14.00
- AVG Volume (30 Days)
- APGE 923.1K
- ALVO 351.5K
- Earning Date
- APGE 11-12-2025
- ALVO 11-12-2025
- Dividend Yield
- APGE N/A
- ALVO N/A
- EPS Growth
- APGE N/A
- ALVO N/A
- EPS
- APGE N/A
- ALVO 0.22
- Revenue
- APGE N/A
- ALVO $562,478,000.00
- Revenue This Year
- APGE N/A
- ALVO $34.94
- Revenue Next Year
- APGE N/A
- ALVO $39.55
- P/E Ratio
- APGE N/A
- ALVO $36.32
- Revenue Growth
- APGE N/A
- ALVO 82.19
- 52 Week Low
- APGE $26.20
- ALVO $7.35
- 52 Week High
- APGE $63.50
- ALVO $13.70
- Technical
- Relative Strength Index (RSI)
- APGE 66.05
- ALVO 41.96
- Support Level
- APGE $54.80
- ALVO $7.77
- Resistance Level
- APGE $57.23
- ALVO $8.50
- Average True Range (ATR)
- APGE 2.61
- ALVO 0.28
- MACD
- APGE -0.18
- ALVO -0.08
- Stochastic Oscillator
- APGE 62.75
- ALVO 10.42
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.